Dr. Dhruvi Hasnani
Consultant Diabetologist & HOD Clinical Research
Founder of Niramaya Diabetes & Obesity Care Center Co-Founder of Rudraksha Institute of Medical Sciences
About the Doctor
Dr. Dhruvi Hasnani is a distinguished Consultant Diabetologist and Head of Department of Clinical Research at Rudraksha Institute of Medical Sciences, which she co-founded.
With extensive qualifications and experience in diabetes care, pediatric diabetes, and clinical research, she has made significant contributions to the field of diabetology both nationally and internationally.
Academic Qualifications
Medical Degrees
- MD. Physician
- FRCP - Edinburgh (UK)
- FACP - American College of Physicians
Post Graduate Diplomas
- PG Diploma Endocrinology, University of South Wales, UK
- PG Diploma Diabetes RSSDI
- PG DIP Diabetes EASD (Europe)
Fellowships
- Fellow Pediatric Diabetes ISPAD (USA)
- Fellow Diabetes India
- Fellowship in Research from University of ULM, Germany, 2017
Certifications
- Certificate Course in Evidence Based Diabetes Mellitus – Public Health Foundation of India
- Certificate Course in Diabetic Retinopathy - Public Health Foundation of India
- Certificate Course in Gestational Diabetes Mellitus - Public Health Foundation of India
- Certificate Course in Management of Hypertension - Public Health Foundation of India
- SCOPE certified Obesity Physician
Professional Experience
Founder & Director
Niramaya Diabetes & Obesity Care Center
Co-founder – Diabetologist
Rudraksha Institute of Medical Sciences
Associate Director – Medical Affairs
Eli Lilly
Led the obesity team for launch readiness and strategy building for Tirzepatide
Co-founder & Consultant Diabetologist
Rudraksha Institute of Medical Sciences, Ahmedabad
Head of Department - Clinical Research
Assistant Diabetologist
Diacare – Diabetes Care & Hormone Clinic
Additional Positions
- Executive Committee – DPPC – publication committee for Sweet ev
- Associate Editor – Journal of Clinical Diabetology
- National Coordinator - Sweet India Registry (Registry for Pediatric Diabetes)
- Past Project Coordinator - Changing Diabetes In Children (CDIC by Novo Nordisk), Life For A Child (LFAC)
- Past Interim Committee member for IDF Young Leaders in Diabetes
Office Bearer
- Treasurer - RSSDI Gujarat Chapter 2016 - ongoing
- ISPAD Jenious Ambassador – 2021-2022
- DPPC committee member – SWEET ev
- Secretary – Indian Podiatry Association - Gujarat Chapter – 2025-2028
Awards & Achievements
Campaigns & Initiatives
RSSDI Sakhi Campaign
Awareness and intervention in field of Diabetes & Women
DIWWAAS Initiative
Increasing awareness regarding Diabetes & Its prevention in Women
Defeat Diabetes
National Campaign to increase awareness for Diabetes
Pediatric Diabetes Awareness Campaign
Improving the quality of lives of kids with Diabetes – DRIMS charitable trust
D Connect
Empowering HCPs through education and team support. Created 10 satellite centers through telemedicine
Obesity Free Gujarat
Advocacy and awareness campaign
Insulinisation for India
Campaign to make initiation and titration of insulin easy for HCPs and people with Diabetes
Publications
Saiyed M, Hasnani D, et al. Worldwide differences in childhood type 1 diabetes: The SWEET experience. Pediatr Diabetes. 2021 Mar;22(2):207-214.
Jethwani P, Saboo B, Hasnani D, et al. Management of children and adolescents having type 1 diabetes during COVID-19 pandemic in India: challenges and solutions. Int J Diabetes Dev Ctries. 2020 Sep 15:1-5.
Svensson J, Schwandt A, Hasnani D, et al. The influence of treatment, age at onset, and metabolic control on height in children and adolescents with type 1 diabetes-A SWEET collaborative study. Pediatr Diabetes. 2018 Dec;19(8):1441-1450.
Adolfsson P, Riddell MC, Hasnani D, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes. Pediatr Diabetes. 2018 Oct;19 Suppl 27:205-226.
Pacaud D, Lemay JF, Hasnani D, et al. Contribution of SWEET to improve paediatric diabetes care in developing countries. Pediatr Diabetes. 2016 Oct;17 Suppl 23:46-52.
Witsch M, Kosteria I, Hasnani D, et al. Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience. Pediatr Diabetes. 2016 Oct;17 Suppl 23:7-15.
Saboo B, Singh RB, Hasnani D, et al. Environmental modulators of type 1 diabetes mellitus. Endocrine Oncology and Metabolism. Volume 2, Number 2, 2016, pp. 122-137(16)
Prajapati S, Suthar J, Hasnani D, Chavda V. Adverse Drugs Reaction and Prescribing Pattern of Antidiabetic Medications in Type 2 Diabetes Patients: An Observational Ambispective Study. Clinical Diabetology. 2024;13(3):170-9.
Aashish M, Arindam N, Hasnani D, et al. Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial. Clinical Diabetes and Endocrinology. 2024;10(1):3.
Hasnani D, Jha S, Saboo B, et al. Efficacy of Insulin Degludec/Insulin Aspart (IDegAsp) vs. Insulin Glargine (IGlarU300) in Insulin-Naïve Patients with Type 2 Diabetes: A Retrospective Study. Clinical Diabetology. 2024.
Hasnani D, Saboo B, Chaturvedi A, et al. Current insulinization trends in India. International Journal of Diabetes in Developing Countries. 2023;43(3):363-370.
Chavda V, Jha S, Hasnani D, et al. The efficacy of Tadalafil and Tadalafil+ Dapoxetine in managing sexual dysfunction in individuals with type-2 diabetes mellitus: A clinical study. Journal of Diabetology. 2023;14(1):48.
Maheshwari A, Hasnani D, et al. Assessment of determining factors for severity of NeoCOVIDiabetes in India: A pan India multicentric retrospective study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2023;17(1):102692.
Hasnani D, Chavda V. Saroglitazar: One Molecule for Managing Two Diseases, Type 2 Diabetes and Hypertriglyceridemia. Clinical Diabetology. 2022;11(5):301-302.
Saboo B, Joshi S, Hasnani D, et al. Management of Diabetes during Fasting and Feasting in India. J Assoc Physicians India. 2019 Sep;67(9):70-77.
Hasnani D, Fortes SI, López ACL, Chavda V. Basis in Metabolic Syndrome. Biochemical Mechanisms for Metabolic Syndrome. 2024:17.
Hasnani D. Microvascular complications in Women with DM and their Management. RSSDI Sakhi. 2021.
Hasnani D, Chavda V. Perioperative use of Insulin. Insulin Monogram. 2019.
Hasnani D. Metformin in Young. Frontiers of Diabetes. 2016.
Professional Memberships
Languages
Contact
Niramaya Diabetes & Obesity Care Center
Ahmedabad, Gujarat, India
Visit Website →Rudraksha Institute of Medical Sciences
Ahmedabad, Gujarat, India
Visit Website →Hospital Branches
South Bopal, Ahmedabad
A 227-228, Arohi Galleria, Gala Gymkhana Road, South Bopal, Ahmedabad
Rudraksha Hospital, Bareja
Rajmandir Complex, Rudraksha Hospital Road, Off Bareja Fly Over, Bareja, Ahmedabad
Ghodasar, Ahmedabad
1st Floor, Rupala Complex, Above Royal Enfield Showroom, Ghodasar Cross Road, Ghodasar, Ahmedabad
Niramaya, Nikol, Ahmedabad
20-209, Pushkar Icon, Nikol-Naroda Road, Above Croma Store, Kalyan Chowk, New India Colony, Nikol, Ahmedabad
Krishna Hospital, Nadiad
Krishna Hospital, Near D. P. High School, Santram Road, Nadiad